Research-use targeted NGS kit for BCR::ABL1 breakpoint-region and mutation profiling in human hemato-oncology workflows, supported by GENOVESA bioinformatic analysis.
Manufactured by BioVendor, the fastGEN BCR::ABL1 Cancer Kit is a one-step NGS library workflow for isolated human DNA. It supports laboratories evaluating BCR::ABL1 in Philadelphia chromosome-positive leukemia research and related hemato-oncology sequencing workflows.
Relevant BCR::ABL1 content from the BioVendor product summary, arranged for quick laboratory review.
Targets BCR::ABL1, an important fusion-gene marker in chronic myeloid leukemia research.
Supports Philadelphia chromosome-positive leukemia research where tyrosine kinase inhibitor response is a key area of investigation.
Helps laboratories evaluate mutational status linked with secondary mutations, conformational changes, and treatment-failure research questions.
Covers common BCR::ABL1 breakpoint cluster regions using an NGS-based workflow.
Built on the BioVendor fastGEN system for one-step NGS library preparation.
Designed for Illumina sequencing workflows, with conversion-kit support for other platforms.
BioVendor provides RUO instructions, safety information, sample-sheet resources, application documents, and product brochures to support implementation planning.
Example Instructions for Use (RUO) are available for workflow reference.
MSDS / Safety Information (RUO) resources support laboratory handling review.
fastGEN sample sheet and application documents are listed for run planning.
Brochures include hemato-oncology NGS and fastGEN one-step library workflow resources.
Our team can help with RUO product availability, GENOVESA workflow planning, platform compatibility, and implementation support.
